Sales & Marketing Sponsored Ensuring compliance - The Functional Point of Contact (FPOC)... As has been widely acknowledged, one of the most meaningful steps a business can take is to establish a
News Genentech buys Regor's next-gen CDK inhibitors for $850M Regor Therapeutics Group has agreed to sell its portfolio of CDK inhibitors to Roche's Genentech for an upfront cash payment of $850 million.
R&D Sponsored Beyond clinical: Boosting recruitment and retention with SDO... The success of clinical trials hinges on a complex array of factors, many of which extend beyond traditional clinical care.